AzTrials
AzTrials

Hospital Associated DisabilityPhase 2GHOSTLY+NCT07294131

Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an Electromyography-driven Serious Game.

A Phase 2 study testing Gamified isometric strength training with blood flow restriction and Standard Physiotherapy in people with Hospital Associated Disability and Immobility, run by Vrije Universiteit Brussel at 3 sites in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study investigates a new training method designed to help older adults preserve their muscle strength during hospitalization. When older adults are admitted to the hospital and spend long periods in bed, their muscles can weaken very quickly. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
What is being tested?
Gamified isometric strength training with blood flow restriction and Standard Physiotherapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
3 sitesBelgium
Study dates
5 Jun 2026to 1 Jan 2029
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Hospitalized, and expected to remain hospitalized for approximately 14 days
  • 65+ yrs
  • Unable to bear weight or transfer independently and at high risk of muscle strength loss due to prolonged immobility
  • Therapists will be included if
  • They are licensed physiotherapists employed at one of the three participating clinical sites
  • They are involved in the daily rehabilitation of hospitalized older adults.

Who cannot join

  • Contraindications for physical exercise as assessed by the treating physician using the risk assessment tool proposed by Kacin et al. (2015) (can be overruled by the physician)
  • Contraindications for blood flow restriction as assessed by the treating physician (can be overruled by the physician)
  • Cognitive impairment (MMSE score < 19)
  • Any condition that renders the patient unable to understand instructions or safely interact with the GHOSTLY+ system
  • THERAPISTS
  • Therapists will be excluded from participation if
Show all 9Show fewer
  • They are unable or unwilling to complete the GHOSTLY+ training
  • They are not directly involved in the care of eligible patients during the study period
  • They express any conflict of interest or ethical concern that may compromise the integrity of the study

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Eva Swinnen, prof. dr. contact

+32 (0)2 477 45 27

eva.swinnen@vub.be

Mahyar Firouzi, Dr. contact

+32 472 55 47 56

mahyar.firouzi@vub.be

Belgium3 sites, 3 recruiting
  • Universitair Ziekenhuis Antwerpen

    Antwerp

    Gaetane Stassijns, prof. dr., gaetane.stassijns@uza.be

    Not yet recruiting
  • Universitair Ziekenhuis Brussel

    Brussels

    Siddhartha Lieten, prof. dr., siddhartha.lieten@uzbrussel.be

    Recruiting
  • Universitair Ziekenhuis Leuven

    Leuven

    Marian Dejaeger, prof. dr., marian.dejaeger@uzleuven.be

    Recruiting

Other trials in Belgium

About this study

Official title: Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an EMG-driven Serious Game

This study investigates a new training method designed to help older adults preserve their muscle strength during hospitalization. When older adults are admitted to the hospital and spend long periods in bed, their muscles can weaken very quickly. This condition is known as hospital-associated disability (HAD), and it can lead to longer hospital stays, reduced independence, and an increased risk of complications or even death. Conventional strength training with heavy weights is often too demanding or unsafe for frail patients, especially just after surgery or illness. As a safer alternative, this study combines light muscle exercises with a medically validated technique called blood flow restriction (BFR), which gently reduces blood flow to the leg to boost the effects of light exercises.

To make training more engaging and personalized, the GHOSTLY+ system was developed. This system consists of a game played on a tablet that responds to muscle activity through sensors placed on the skin. While playing, patients perform isometric muscle contractions (exercises where the muscles tighten without moving the joint) that help to maintain and rebuild strength. The system was carefully designed in collaboration with patients and therapists, and it has already been tested in a smaller pilot study at UZ Brussel.

Read more

The current study is a multicenter randomized controlled trial, taking place at UZ Brussel, UZ Antwerpen, and UZ Leuven. A total of 120 patients aged 65 or older will be recruited, all of whom are hospitalized and are unable to bear weight or transfer (e.g., from lying to seated position). Participants will be randomly assigned to one of two groups. One group receives standard physiotherapy. The other group receives standard therapy plus the GHOSTLY+ training program.

Those in the GHOSTLY+ group will train at least five times per week for two weeks, or until discharge from the hospital. Each training session lasts approximately 30 minutes and involves three sets of 12 muscle contractions, guided by the game. The difficulty is adapted to the individual's muscle strength, which is measured at the beginning of the training using a built-in calibration protocol. During the session, a smart cuff is applied to the upper leg to partially restrict blood flow - a technique shown to safely enhance muscle adaptation. The cuff is inflated to 50% of the individual's arterial occlusion pressure and deflated after the session ends. Before beginning, participants receive a short training session with a physiotherapist. Our pilot study (Debeuf et al., 2025) shows that most patients can use the system independently after about one hour of instruction.

Measurements and evaluations take place at three timepoints: before starting the training, after one week, and again at discharge. The main goal is to assess leg muscle strength, which will be measured using a handheld device called a dynamometer. In addition, researchers will collect information on:

  • Muscle mass, via ultrasound of the thigh muscle
  • Functional capacity, using a 30-second sit-to-stand test and a walking scale (Functional Ambulation Category)
  • An index of independence in activities of daily living (Katz scale)
  • Cognitive functioning, using the Mini-Mental State Examination (MMSE)
  • Time spent bedridden and total length of hospital stay
  • Therapy adherence and user experience, via usage data and questionnaires
  • Muscle activity signals, such as fatigue, recorded during gameplay
  • Implementation outcomes (collected via surveys, interview, site logbooks)

The study will also assess how easily the GHOSTLY+ system can be implemented in real hospital environments. This includes evaluations of user satisfaction, therapist feedback, and how consistently the system is used across hospital settings. Information will be gathered through structured interviews, surveys, and data logs from the app. These insights are crucial to understanding whether GHOSTLY+ can be broadly adopted in other hospitals in the future.

Blood flow restriction training is considered very safe when applied correctly and is already used in rehabilitation clinics and sports medicine worldwide. Over 300,000 sessions have been conducted internationally, with a very low rate of complications. Minor discomfort, such as temporary tightness or muscle fatigue, may occur, but the risk of serious side effects is extremely small.

By participating in this study, patients may benefit from improved muscle strength, reduced time spent in bed, and greater physical independence at discharge. The study also contributes to the development of more effective and enjoyable rehabilitation methods for older adults in hospitals.

Read the detailed description

Hospitalization places older adults at significant risk for hospital-associated disability (HAD), a condition marked by a rapid and often severe decline in muscle strength and function due to immobility. Research has shown that adults aged 65 and older can lose up to 15% of their lower-limb strength within a single week of bed rest, and as much as 5% of muscle mass per day. These declines not only prolong the length of hospital stay but also increase dependence, impair mobility, and elevate the risk of mortality. While high-load resistance training is considered the gold standard for preventing muscle loss, it is often contraindicated or simply unfeasible for frail or post-surgical patients. This creates an urgent need for effective, low-impact alternatives to preserve physical function during hospitalization.

Blood flow restriction (BFR) training has emerged as one such alternative. It works by partially occluding arterial blood flow and fully restricting venous return in a limb using a pressure cuff, thereby enhancing the effects of low-load exercise. BFR has been demonstrated to stimulate muscle hypertrophy and strength gains in various populations, including older adults, and has been shown to be safe in over 300,000 reported clinical sessions. In addition to physical limitations, another major challenge in hospital rehabilitation is poor adherence. Many patients fail to complete unsupervised therapy exercises, largely due to low motivation. Serious games - interactive applications designed with a therapeutic goal - have shown promise in improving engagement, but most are not designed specifically for clinical use or individualized for the needs of hospitalized older adults.

To address these challenges, the GHOSTLY+ system was developed. GHOSTLY+ is a mobile rehabilitation solution combining gamified muscle training with BFR, designed to be used during non-therapy time in hospitalized older adults. The system is based on a serious game app that transforms muscle contractions, measured via surface electromyography (EMG), into in-game actions. By engaging patients in a playful yet physiologically grounded environment, the system aims to increase motivation and ensure proper exercise intensity, even without the use of weights or active movement. GHOSTLY+ includes automated difficulty adjustment based on real-time EMG input and follows evidence-based parameters for strength training: isometric contractions at approximately 75% of each patient's maximum voluntary contraction (MVC), performed three times per session with 12 repetitions each set.

The clinical study described here is a multicenter, randomized controlled trial (RCT) using a Hybrid Type 1 design. The trial will be conducted at three hospitals in Belgium (UZ Brussel, UZ Antwerpen, and UZ Leuven) and will enroll 120 older adults aged 65 years or above who are hospitalized, unable to bear weight or transfer independently, are expected to remain hospitalized for approximately 14 days, and are at high risk of muscle strength loss due to prolonged immobility. Participants will be randomly assigned to one of two groups. The control group will receive standard physiotherapy as prescribed in the hospital. The intervention group will receive standard care supplemented with the GHOSTLY+ system. Participants will use GHOSTLY+ for at least five sessions per week, over two weeks or until discharge, depending on their hospital stay duration.

Each GHOSTLY+ session begins with the application of a smart BFR cuff to the upper thigh of the target leg. The cuff automatically measures the arterial occlusion pressure (AOP) and inflates to 50% of this value, a level known to be effective while minimizing discomfort. Participants are then guided through an in-app calibration process in which they perform three maximal isometric contractions. Based on these readings, the system determines the individual's MVC and sets the game difficulty to 75% of that value. During gameplay, patients must complete three levels per session, with each level representing a set of twelve muscle contractions. Rest periods of two minutes are provided between sets. Based on a previous proof-of-concept study conducted at UZ Brussel (Debeuf et al., 2025), most patients are able to use the system independently after one hour of training. Physiotherapists at each site will be trained to guide this initial setup until patients are independently capable of setting up the GHOSTLY+ system.

The primary outcome of this study is lower-limb muscle strength at hospital discharge, assessed using a handheld MicroFet dynamometer. Secondary outcomes include muscle mass measured via ultrasound imaging of the rectus femoris, functional performance assessed through the 30-second sit-to-stand test and the Functional Ambulation Category, independence in activities of daily living using the Katz scale, time spent bedridden, total length of hospital stay, and patient-reported outcomes related to satisfaction and usability of the intervention. Cognitive status will be assessed using the Mini-Mental State Examination (MMSE), and additional analysis will be performed on EMG data to extract neuromuscular parameters such as signal amplitude and fatigue index. In addition to clinical and physiological data, patients and therapists will participate in implementation data collection via surveys, interviews, and site logbooks, in line with the Consolidated Framework for Implementation Research (CFIR).

Data will be collected at three time points: before the intervention (baseline), at the end of the first week, at the end of two weeks, or at hospital discharge if earlier. Randomization will be performed using a web-based system, with assessors blinded to group allocation to reduce bias. Participants will receive a study-specific ID and will be instructed not to disclose their group assignment to those collecting outcome measures.

Beyond evaluating clinical efficacy, the trial incorporates a robust implementation evaluation. Using the Consolidated Framework for Implementation Research (CFIR) and Proctor's framework, the study will examine key real-world indicators such as acceptability, adoption, fidelity, feasibility, penetration, and sustainability. Data will be gathered through staff surveys, administrative records, structured interviews, app usage data, and focus groups with healthcare professionals and patients. The qualitative data will be analyzed using content analysis and reflexive thematic analysis to identify implementation facilitators and barriers.

The study is powered to detect a 15% difference in lower-limb strength preservation between the intervention and control groups. Analysis will include repeated measures ANOVA, regression modeling, and subgroup analysis to explore the impact of baseline mobility status or cognitive performance. All data will be monitored for quality and completeness, and any serious adverse events will be reported to the competent authorities following the applicable safety guidance under the EU Medical Device Regulation.

Following trial completion, the research team will prepare an implementation package, including an e-learning training module for clinical staff, a Grol \& Wensing-based implementation guideline, and a business case for broader adoption. Results will be disseminated through academic publications, clinician workshops, hospital presentations, and patient information campaigns.

In summary, this trial evaluates GHOSTLY+, a novel rehabilitation system combining blood flow restriction and EMG-guided gamified strength training for hospitalized older adults. It is designed to preserve muscle strength, reduce physical decline during bedrest, and boost adherence to therapy using interactive digital technology. By embedding implementation science into its structure, the study aims to not only prove the effectiveness of GHOSTLY+ but also support its sustainable integration into routine hospital care.

Being tested
Gamified isometric strength training with blood flow restriction, Standard Physiotherapy
Keywords
hospital-associated disability, HAD, muscle strength loss, blood flow restriction, BFR, serious games, EMG-driven rehabilitation, geriatric rehabilitation, older adults, lower-limb strength, non-weight-bearing, randomized controlled trial, RCT, physical deconditioning, hospitalization, electromyography, digital rehabilitation, implementation science, rehabilitation technology, exergaming

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gamified isometric strength training with blood flow restrictionDevice

    Also called GHOSTLY+

    GHOSTLY+ is an interactive, EMG-driven serious game combined with blood flow restriction (BFR) therapy. Participants will undergo isometric quadriceps contractions guided by gameplay, with each session consisting of 3 sets of 12 contractions at 75% of their maximum voluntary contraction (MVC), as determined by in-app calibration. BFR will be applied using a smart cuff inflated to 50% of the participant's arterial occlusion pressure (AOP). Sessions will be performed independently by the patient during non-therapy time, with a minimum of 5 sessions per week over a 2-week period (or until discharge).

  • Standard PhysiotherapyOther

    Also called Standard Care

    Usual standard-of-care physiotherapy as per hospital guidelines. This typically consists of supervised therapeutic sessions prescribed by the clinical team, including mobility exercises, transfer practice, and functional strengthening, depending on the patient's clinical needs and recovery stage. Participants do not perform structured lower-limb strength training outside of formal therapy sessions.

Study groups in NCT07294131
Study groupRoleWhat they receive
Control ArmActive comparatorParticipants in the control group will receive standard physiotherapy according to the usual clinical care procedures at the participating hospital site. No additional strength training, exercise tools, or exergaming interventions will be provided. Participants will be encouraged to remain active according to standard rehabilitation protocols but will not engage with the GHOSTLY+ system or any equivalent unsupervised strength training intervention.
Receives: Other: Standard Physiotherapy
Intervention ArmExperimentalParticipants randomized to the intervention group will receive standard physiotherapy according to hospital protocol, supplemented with the GHOSTLY+ system.
Receives: Device: Gamified isometric strength training with blood flow restriction; Other: Standard Physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal isometric muscle strength

    Maximal isometric muscle strength of the lower limbs will be assessed using a handheld dynamometer (MicroFET or equivalent). The test involves measuring the peak isometric force generated by the quadriceps muscle group during a voluntary contraction against resistance, while the participant is in a standardized seated position. Each participant will perform three maximal voluntary contractions (MVCs) with sufficient rest between trials. The highest recorded peak force (Newtons) will be used as the representative value. Testing will be conducted at three time points: baseline (T0), after one week (T1), and at two weeks or at the time of hospital discharge, whichever occurs first (T2). Outcome assessors are blinded to group allocation. The change in maximal isometric quadriceps strength (Newtons) from baseline to discharge will serve as the primary endpoint to evaluate the intervention's effectiveness in preserving muscle strength during hospitalization.

    Measured: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).

Secondary outcomes (16)
  1. Electromyography (EMG) Signal Analysis

    Analyses will be performed on EMG data to extract the neuromuscular parameter: signal amplitude.

    Measured: At the end of week 1, and the end of treatment at 2 weeks (or until hospital discharge if earlier).

  2. Cross-sectional area of the Rectus Femoris Muscle

    The muscle mass of the m. rectus femoris will be assessed using a bedside ultrasound system. The cross-sectional area (CSA) of the muscle will be measured in a supine position at a standardized mid-thigh location. Assessments will occur at baseline (T0), week 1 (T1), and discharge (T2). This outcome is intended to capture muscle architecture changes associated with strength loss or preservation.

    Measured: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).

  3. Functional performance - 30 second sit-to-stand test

    If medically permitted (i.e., participant is weight-bearing), functional lower-limb endurance will be measured using the 30-second sit-to-stand test (30s-STS). Participants will be asked to rise from a standardized chair to a full standing position and sit back down as many times as possible in 30 seconds. Standardized instructions and encouragement will be used. This test is a validated measure of functional strength and endurance. Performance will be assessed at T0, T1, and T2.

    Measured: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).

  4. Functional ambulation category (FAC)

    The Functional Ambulation Category (FAC) is a 6-point scale used to assess the level of independence in walking. It ranges from 0 (non-functional ambulation) to 5 (independent ambulation in all environments). Assessment is performed at T0, T1 and T2. FAC will help determine the extent to which patients regain or retain ambulatory capacity during hospitalization.

    Measured: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).

  5. Time spent bed- or chair-ridden

    The cumulative number of hours spent bed- or chair-ridden during the hospital stay will be recorded at T2, using daily nursing records and physiotherapy logs. This outcome serves as an indicator of mobility and physical activity during hospitalization.

    Measured: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).

  6. Hospital length of stay

    The total length of hospital stay, from admission to discharge, will be extracted from hospital records at T2. This metric will help determine whether the intervention has an effect on overall hospitalization duration, potentially through earlier recovery or functional independence.

    Measured: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).

  7. Adherence: number of sessions

    Adherence to the intervention will be tracked automatically through usage logs embedded in the GHOSTLY+ software, and will be extracted at T1 and T2. Metric 1: number of sessions completed.

    Measured: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).

  8. Adherence: duration of play

    Adherence to the intervention will be tracked automatically through usage logs embedded in the GHOSTLY+ software, and will be extracted at T1 and T2. Metric 2: duration of play per session.

    Measured: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).

  9. Adherence: percentage of completed repetitions

    Adherence to the intervention will be tracked automatically through usage logs embedded in the GHOSTLY+ software, and will be extracted at T1 and T2. Metric 3: percentage of completed repetitions (%).

    Measured: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).

  10. Usability and satisfaction

    Patient-reported usability and satisfaction with the GHOSTLY+ system will be measured using customized questionnaires developed for this study. It will assess ease of use, clarity of instructions, perceived benefit, and overall satisfaction using Likert-scale questions. Administered at discharge (T2), the goal is to evaluate patient experience and barriers/facilitators for future implementation.

    Measured: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).

  11. Katz Index of Independence in Activities of Daily Living

    The purpose of the Index of ADL, or Katz ADL, is to monitor the prognosis and treatment of older adults and chronically ill individuals. In particular, the Katz ADL measures a person's independence in common activities of daily living (ADL).

    Measured: At enrollment, and at the end of treatment at 2 weeks (or until hospital discharge if earlier).

  12. EQ-5D QOL

    The EQ-5D is a standardized instrument for measuring health-related quality of life (QoL), consisting of five dimensions: mobility, self-care, activities of daily living, pain/discomfort, and anxiety/depression. It consists of a descriptive system and a visual analog scale (EQ VAS).

    Measured: At enrollment, and at the end of treatment at 2 weeks (or until hospital discharge if earlier).

  13. Charlson Comorbidities Index

    The Charlson Comorbidity Index predicts the mortality for a patient who may have a range of concurrent conditions (considering a total of 17 categories). A score of zero means that no comorbidities were found; the higher the score, the higher the predicted mortality rate and the lower the predicted ten-year survival.

    Measured: At enrollment.

  14. Mini Mental State Examination

    The Mini-Mental State Examination (MMSE) is a brief, 11-question test used to screen for cognitive impairment by assessing a person's orientation, attention, memory, language, and visual-spatial skills.

    Measured: At enrollment.

  15. Usefulness, Satisfaction, and Ease of Use (USE)

    The Usefulness, Satisfaction, and Ease of Use (USE) questionnaire is a validated 30-item scale designed to assess users' perceived usefulness, satisfaction, and ease of use of a system. Scores reflect how well the system supports task performance, how pleasant it is to use, and how intuitively users can interact with it.

    Measured: At 2 weeks (or until hospital discharge if earlier).

  16. System Usability Scale (SUS)

    The System Usability Scale (SUS) is a widely used 10-item questionnaire that provides a global measure of perceived system usability.Higher scores indicate better usability.

    Measured: At 2 weeks (or until hospital discharge if earlier).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2025
  2. Study start5 Jun 2026
  3. Primary completion1 Jan 2029 (estimated)
  4. Study completion1 Jan 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a multicenter, two-arm, parallel-group randomized controlled trial (RCT) using a Hybrid Type 1 effectiveness-implementation design.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07294131
Sponsor's protocol ID
CIV-25-06-053274
Other IDs
T000425N
Acronym
GHOSTLY+
Status last verified
Jun 2026
First submitted
17 Dec 2025
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: Individual participant data will not be shared directly. Where possible, data underlying the published results will be shared in fully anonymised form, together with metadata, after completion of the analysis. Data will be shared in accordance with institutional guidelines and applicable data protection legislation (GDPR), upon reasonable request to the corresponding author and subject to a data use agreement.

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Gamified isometric strength training with blood flow restriction and Standard Physiotherapy in people with Hospital Associated Disability and Immobility, run by Vrije Universiteit Brussel at 3 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eva Swinnen, prof. dr. (+32 (0)2 477 45 27, eva.swinnen@vub.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal isometric muscle strength (time frame: From enrollment to the end of treatment at 2 weeks (or until hospital discharge if earlier).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in